2Stepanova V, Lebedeva T, Kuo A, et al. Nuclear translocation of uro- kinase - type plasminogen activator [ J]. Blood, 2008, 112 ( 1 ) : 100 - 110.
3Asuthkar S, Stepanova V, Lebedeva T, et al. Multifunctional roles of urokinase plasminogen activator (uPA) in cancer sternness and che- morcsistance of pancreatic cancer [ J ]. Mol Biol Cell, 2013, 24 ( 17 ) : 2620 - 2632.
4Wu YJ, Neoh CA, Tsao CY, et al. Sinulariolide suppresses human hepatocellular carcinoma cell migration and invasion by inhibiting ma- trix metalloproteinase - 2/- 9 through MAPKs and P13K/Akt signa- ling Pathways[J]. Int J Mol Sci, 2015, 16(7): 16469-16482.
5Lampelj M, Arko D, Cas -Sikosek N,et al. Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type - 1 (PAI - 1 ) in breast cancer - correlation with traditional prognostic factors [ J ]. Radiol Onco1,2015,49 (4) :357 - 364.
6Noh H, Hong S, Huang S. Role of urokinase receptor in tumor pro- gression and development [ J ]. Theranostics, 2013,3 ( 7 ) :487 - 495.
7Dutta S, Bandyopadhyay C, Bottero V, et al. Angiogenin interacts with the plasminogen activation system at the cell surface of breast cancer cells to regulate plasmin formation and cell migration[ J]. Mol Oncol, 2014,8(3) :483 -507.
9Asuthkar S, Gondi CS, Nalla AK, et al. Urokinase - type plasmino- gen activator receptor (uPAR) - mediated regulation of WNT/β - catenin signaling is enhanced in irradiated medulloblastoma cells[ J]. J Biol Chem, 2012,287 ( 24 ) :20576 - 20589.
10Park JS, Park JH, Khoi PN, et al. MSP - induced RON activation upreguIates uPAR expression and cell invasiveness via MAPK, AP - 1 and NF - κB signals in gastric cancer cells [ J ]. Carcinogenesis, 2011,32(2) :175 - 181.
